A name that means to defend
Amyneion takes its name from the Ancient Greek amýnō: to defend, to protect, to ward off.
The immune system exists to defend us. In autoimmune disease, that same defense can lose its sense of what belongs and what does not, turning protection against the body itself.
We chose the name Amyneion because it captures the paradox at the heart of autoimmune disease and the reason this company exists: to help make clinical research more accessible to the patients who may benefit from it, while giving the physicians who already care for them a meaningful role in that process.
The right patient and the right trial can exist miles apart
I'm Kevin Minn, founder of Amyneion.
I didn't come to healthcare through the traditional path. I'm a health-tech entrepreneur and software engineer who became fascinated by a problem that seemed increasingly difficult to ignore: extraordinary medical research can be happening, promising treatments can be in development, and yet the right patient and the right clinical trial can still exist miles apart without ever finding each other.
In autoimmune disease, that gap matters enormously. Patients often live with complex conditions for years. Their physicians know their histories. Their clinical records contain information that could matter to research. Yet participation in clinical trials remains concentrated in relatively few places, and identifying eligible patients is still far harder than it should be.
I started building Amyneion around a simple question:
What if clinical research could reach patients where they already receive care?
That question became a company.
Amyneion is being built to bring together clinical research, community medicine, and technology so that more patients can have the opportunity to participate in the development of what comes next.
For me, the name is also a reminder of what medicine is ultimately supposed to do.
To defend. To protect. To help.
And when the body's own defense becomes the disease, we should be relentless in searching for better answers.